Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus

Recent advances in virus-like nanoparticles against Middle East respiratory syndrome-related coronavirus (MERS-CoV) can initiate vaccine production faster for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), while ensuring the safety, easy administration, and long-term effects. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemzadeh, Alireza, Avan, Amir, Ferns, Gordon A., Khazaei, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837099/
https://www.ncbi.nlm.nih.gov/pubmed/32684497
http://dx.doi.org/10.1016/j.vaccine.2020.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837099/
https://www.ncbi.nlm.nih.gov/pubmed/32684497
http://dx.doi.org/10.1016/j.vaccine.2020.07.003

Ejemplares similares